Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy.
Richardson JR, Schöllhorn A, Gouttefangeas C, Schuhmacher J. Richardson JR, et al. Among authors: schuhmacher j. Cancers (Basel). 2021 Feb 3;13(4):596. doi: 10.3390/cancers13040596. Cancers (Basel). 2021. PMID: 33546283 Free PMC article. Review.
Adhering to adhesion: assessing integrin conformation to monitor T cells.
Gouttefangeas C, Schuhmacher J, Dimitrov S. Gouttefangeas C, et al. Among authors: schuhmacher j. Cancer Immunol Immunother. 2019 Nov;68(11):1855-1863. doi: 10.1007/s00262-019-02365-1. Epub 2019 Jul 15. Cancer Immunol Immunother. 2019. PMID: 31309255 Review.
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial.
Schuhmacher J, Heidu S, Balchen T, Richardson JR, Schmeltz C, Sonne J, Schweiker J, Rammensee HG, Thor Straten P, Røder MA, Brasso K, Gouttefangeas C. Schuhmacher J, et al. J Immunother Cancer. 2020 Nov;8(2):e001157. doi: 10.1136/jitc-2020-001157. J Immunother Cancer. 2020. PMID: 33184050 Free PMC article. Clinical Trial.
Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity.
Schöllhorn A, Schuhmacher J, Besedovsky L, Fendel R, Jensen ATR, Stevanović S, Lange T, Rammensee HG, Born J, Gouttefangeas C, Dimitrov S. Schöllhorn A, et al. Among authors: schuhmacher j. Front Immunol. 2021 Mar 29;12:626308. doi: 10.3389/fimmu.2021.626308. eCollection 2021. Front Immunol. 2021. PMID: 33854501 Free PMC article.
CAF-immune cell crosstalk and its impact in immunotherapy.
Maia A, Schöllhorn A, Schuhmacher J, Gouttefangeas C. Maia A, et al. Among authors: schuhmacher j. Semin Immunopathol. 2023 Mar;45(2):203-214. doi: 10.1007/s00281-022-00977-x. Epub 2022 Dec 8. Semin Immunopathol. 2023. PMID: 36480035 Free PMC article. Review.
Mass spectrometry-based identification of a B-cell maturation antigen-derived T-cell epitope for antigen-specific immunotherapy of multiple myeloma.
Bilich T, Nelde A, Bauer J, Walz S, Roerden M, Salih HR, Weisel K, Besemer B, Marcu A, Lübke M, Schuhmacher J, Neidert MC, Rammensee HG, Stevanović S, Walz JS. Bilich T, et al. Among authors: schuhmacher j. Blood Cancer J. 2020 Feb 28;10(2):24. doi: 10.1038/s41408-020-0288-3. Blood Cancer J. 2020. PMID: 32111817 Free PMC article.
Transport Properties and Local Ions Dynamics in LATP-Based Hybrid Solid Electrolytes.
Boaretto N, Ghorbanzade P, Perez-Furundarena H, Meabe L, López Del Amo JM, Gunathilaka IE, Forsyth M, Schuhmacher J, Roters A, Krachkovskiy S, Guerfi A, Armand M, Martinez-Ibañez M. Boaretto N, et al. Among authors: schuhmacher j. Small. 2024 Mar;20(10):e2305769. doi: 10.1002/smll.202305769. Epub 2023 Oct 24. Small. 2024. PMID: 37875738
89 results